Case series identifies ferritin as a reliable marker for iron deficiency in postpartum hemorrhage patients, suggesting further validation is needed.
Postpartum hemorrhage (PPH) is a leading cause of maternal morbidity and mortality, complicating 2% to 4% of US deliveries and exacerbating iron deficiency anemia. Ferritin is the primary biomarker for iron deficiency (ferritin <30 µg/mL), yet its reliability as a marker of iron deficiency in the acute setting of PPH remains uncertain because it also functions as an acute-phase reactant. In this case series, 10 iron-deficient women who experienced PPH following cesarean delivery all maintained ferritin <30 µg/mL postoperatively. Ferritin remained a reliable marker for iron deficiency following acute PPH in women with pre-existing iron deficiency. These observations highlight the need for larger, prospective studies to further validate ferritin's reliability following PPH.
No takes yet. Share an insight, caveat, or question.
Russo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: